Geneva Advisors’s Aratana Therapeutics, Inc. PETX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | $579K | Buy |
80,118
+2,830
| +4% | +$20.5K | 0.01% | 486 |
|
|
2017
Q1 | $410K | Buy |
77,288
+3,044
| +4% | +$16.1K | 0.01% | 537 |
|
|
2016
Q4 | $533K | Buy |
74,244
+3,206
| +5% | +$23K | 0.01% | 465 |
|
|
2016
Q3 | $665K | Buy |
71,038
+1,130
| +2% | +$10.6K | 0.01% | 412 |
|
|
2016
Q2 | $442K | Sell |
69,908
-1,779
| -2% | -$11.2K | 0.01% | 471 |
|
|
2016
Q1 | $396K | Buy |
71,687
+41,480
| +137% | +$229K | 0.01% | 481 |
|
|
2015
Q4 | $169K | Sell |
30,207
-12,867
| -30% | -$72K | ﹤0.01% | 583 |
|
|
2015
Q3 | $364K | Buy |
43,074
+18,745
| +77% | +$158K | 0.01% | 445 |
|
|
2015
Q2 | $368K | Buy |
24,329
+8,001
| +49% | +$121K | 0.01% | 487 |
|
|
2015
Q1 | $261K | Buy |
16,328
+2,970
| +22% | +$47.5K | ﹤0.01% | 544 |
|
|
2014
Q4 | $238K | Buy |
+13,358
| New | +$238K | ﹤0.01% | 568 |
|